Core biopsy

Rationale

The aim of obtaining a core biopsy is to provide an intact histological sample of an area of clinical or radiological concern. Histological assessment of an intact lesion gives the most sensitive and complete result (Chou and Corder [29]) and should be the procedure of choice. In the case of a malignant result it will provide more detailed information to help guide the initial treatment options. It will be undertaken within the breast assessment clinic following clinical and radiological investigation. Clinical and radiological assessment should be completed prior to intervention to gain a tissue sample as this intervention itself may alter the outcome of the radiological and clinical assessment.
Breast biopsies should be guided by radiological imaging (mammogram, ultrasound or MRI) to reduce the need for repeat samples and to increase accuracy of the sample. In this case the procedure is carried out by a radiological consultant, junior doctor or appropriately trained sonographer. It is appropriate to carry out clinical biopsies, without radiological guidance, in cases of locally advanced lesions and clinically palpably lesions that are not visualized on imaging (Chou and Corder [29]).

Indication

A defined area within the breast or axilla that by clinical or radiological criteria is abnormal.

Contraindication

There is little agreement in research on the absolute need to stop anticoagulants prior to biopsy (Chetlen et al. [28]). Stopping anticoagulant therapy will cause delay and may increase the risk to the patient, depending on the reason for treatment. The latest guidance states that a recent international normalized ratio (INR) check (within the last 5 days or longer if stable) should be available.
  • For a core biopsy it is suggested the INR must be < 4 although there is little evidence (BSBR [20]).
  • If the INR is > 4 then warfarin should be stopped for 3 days and restarted on the day of the biopsy.
  • Patients on aspirin or clopidogrel do not need to stop treatment (BSBR [20]).

Equipment

Biopsy devices/needles

The biopsy device is a cutting needle with a hollow central cavity that is either integral to a disposable single‐use firing apparatus or can be attached to a reusable firing apparatus or ‘gun’. The apparatus is pulled back to hold the needle in a cocked position prior to introducing it into the patient. Releasing the firing mechanism launches or throws the needle forward to a specified penetration depth, typically 22 or 15 mm. As the needle moves forward through the anterior tissue it cuts and holds the sample within the hollow central needle space. An example is shown in Figure 20.16.
image
Figure 20.16  Biopsy device and needle.
Procedure guideline 20.9